Profil

STEFFEN Candy

University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM) > Department of Life Sciences and Medicine (DLSM)

ORCID
0000-0002-9445-0074
Main Referenced Co-authors
ABANKWA, Daniel  (3)
Grossmann, Tom N. (2)
Knuuttila, Matias (2)
MANOHARAN, Ganesh Babu  (2)
PAVIC, Karolina  (2)
Main Referenced Keywords
cancer (1); drug development (1); Galectin-1 (1); Peptide (1); RAS (1);
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (4)

Publications (total 4)

The most downloaded
43 downloads
Steffen, C., Kaya, P., Schaffner-Reckinger, E., & Abankwa, D. (2023). Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society Transactions. doi:10.1042/BST20221343 https://hdl.handle.net/10993/55505

The most cited

6 citations (WOS)

Steffen, C., Kaya, P., Schaffner-Reckinger, E., & Abankwa, D. (2023). Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society Transactions. doi:10.1042/BST20221343 https://hdl.handle.net/10993/55505

STEFFEN, C. (17 October 2023). A protein-interface disrupting 23-mer peptide is a prototypic H-Ras- nanocluster and -signalling disruptor [Paper presentation]. Life sciences Ph.D days 2023, Esch sur Alzette, Luxembourg.

MANOHARAN, G. B., STEFFEN, C., PAVIC, K., Yeste-Vázquez, A., Knuuttila, M., Arora, N., Zhou, Y., Härmä, H., GAIGNEAUX, A., Grossmann, T. N., & ABANKWA, D. (2023). Identification of an H-Ras nanocluster disrupting peptide. Cold Spring Harbor Laboratory. doi:10.1101/2023.09.07.556635

Steffen, C., Kaya, P., Schaffner-Reckinger, E., & Abankwa, D. (2023). Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society Transactions. doi:10.1042/BST20221343
Peer Reviewed verified by ORBi

MANOHARAN, G. B., PAVIC, K., Yeste Vazquez, A., Knuuttila, M., Grossmann, T. N., ABANKWA, D., & STEFFEN, C. (13 September 2022). Identification of a small peptide targeting the Raf/ Galectin interface to disrupt stabilised Ras signalling nanocluster [Paper presentation]. Small G proteins in cellular signalling and disease, Liverpool, United Kingdom.

Contact ORBilu